Controlled shedding of platelet glycoprotein (GP)VI and GPIb–IX–V by ADAM family metalloproteinases

Background: Platelet glycoprotein (GP)VI that binds collagen, and GPIb–IX–V that binds von Willebrand factor, initiate thrombus formation.Objectives: In this study, we investigated the mechanisms of metalloproteinase‐mediated ectodomain shedding that regulate the surface expression of GPVI, GPIbα (the major ligand‐binding subunit) and GPV (that regulates thrombin‐dependent activation via GPIbα).Methods and results: Immunoblotting human platelet lysates using affinity‐purified antibodies against cytoplasmic domains of GPVI, GPIbα or GPV allowed simultaneous analysis of intact and cleaved receptor, and revealed (i) that a significant fraction of GPIbα, but not GPVI, exists in a cleaved state on platelets, even when isolated in the presence of metalloproteinase inhibitor (GM6001) or EDTA; (ii) the same‐sized membrane‐associated fragments of GPVI or GPIbα are generated by phorbol‐ester (PMA), the mitochondrial‐targeting reagent CCCP, the calmodulin inhibitor W7, or the thiol‐modifying reagent, N‐ethylmaleimide, that directly activates ADAM10/ADAM17; and (iii) GPV is shed by both metalloproteinase‐ and thrombin‐dependent mechanisms, depending on the concentration of thrombin. Based on the predicted cleavage area defined by these studies, ADAM10, but not ADAM17, cleaved a GPVI‐based synthetic peptide within the extracellular membrane‐proximal sequence (PAR^Q243YY) as analyzed by MALDI‐TOF‐MS. In contrast, ADAM17, but not ADAM10, cleaved within the GPIbα‐based peptide (LRG^V465LQ). Both ADAM10 and ADAM17 cleaved within a GPV‐based peptide (AQP^V494TT). Metalloproteinase‐mediated shedding of GPIbα from GPIb‐IX‐transfected or GPVI‐transfected cells induced by W7 or N‐ethylmaleimide was inhibited by mutagenesis of sequences identified from peptide analysis.Conclusions: These findings suggest surface levels of GPVI, GPIbα and GPV may be controlled by distinct mechanisms involving ADAM10 and/or ADAM17.

[1]  José A López,et al.  The glycoprotein Ib-IX-V complex , 2007 .

[2]  D. Wagner,et al.  The role of platelet adhesion receptor GPIbα far exceeds that of its main ligand, von Willebrand factor, in arterial thrombosis , 2006, Proceedings of the National Academy of Sciences.

[3]  J. Cazenave,et al.  Plasma glycoprotein V levels in the general population: Normal distribution, associated parameters and implications for clinical studies , 2006, Thrombosis and Haemostasis.

[4]  J. Whisstock,et al.  Leucine-rich Repeats 2-4 (Leu60-Glu128) of Platelet Glycoprotein Ibα Regulate Shear-dependent Cell Adhesion to von Willebrand Factor* , 2006, Journal of Biological Chemistry.

[5]  E. Kremmer,et al.  Expression of platelet collagen receptor glycoprotein VI is associated with acute coronary syndrome. , 2006, European heart journal.

[6]  P. Newman,et al.  Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents. , 2006, Blood.

[7]  David C. Lee,et al.  Aspirin Induces Platelet Receptor Shedding via ADAM17 (TACE)* , 2005, Journal of Biological Chemistry.

[8]  M. Pelto-huikko,et al.  Shedding light on ADAM metalloproteinases. , 2005, Trends in biochemical sciences.

[9]  B. Nieswandt,et al.  Evidence for a Role of ADAM17 (TACE) in the Regulation of Platelet Glycoprotein V* , 2005, Journal of Biological Chemistry.

[10]  B. Nieswandt,et al.  Relative antithrombotic effect of soluble GPVI dimer compared with anti-GPVI antibodies in mice. , 2005, Blood.

[11]  Y. Ozaki,et al.  Glycoprotein VI is associated with GPIb-IX-V on the membrane of resting and activated platelets , 2004, Thrombosis and Haemostasis.

[12]  J. Villeval,et al.  Platelet activation induces metalloproteinase-dependent GP VI cleavage to down-regulate platelet reactivity to collagen. , 2005, Blood.

[13]  Robert K Andrews,et al.  Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase. , 2004, Blood.

[14]  D. Wagner,et al.  Tumor Necrosis Factor-&agr;-Converting Enzyme (ADAM17) Mediates GPIb&agr; Shedding From Platelets In Vitro and In Vivo , 2004 .

[15]  P. Newman,et al.  Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surface. , 2004, Blood.

[16]  B. de Strooper,et al.  Cell–matrix interaction via CD44 is independently regulated by different metalloproteinases activated in response to extracellular Ca2+ influx and PKC activation , 2004, The Journal of cell biology.

[17]  D. Wagner,et al.  GPVI down-regulation in murine platelets through metalloproteinase-dependent shedding , 2004, Thrombosis and Haemostasis.

[18]  J. Sixma,et al.  The role of collagen in thrombosis and hemostasis , 2004, Journal of thrombosis and haemostasis : JTH.

[19]  C Caltagirone,et al.  Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease , 2004, Neurology.

[20]  J. Hartwig,et al.  Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro-aged or -injured mouse platelets. , 2003, Blood.

[21]  S. Watson,et al.  GPVI levels in platelets: relationship to platelet function at high shear. , 2003, Blood.

[22]  E. Kojro,et al.  Tumor necrosis factor-alpha converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation. , 2003, European journal of biochemistry.

[23]  Changdong Liu,et al.  Fc Rγ-independent Signaling by the Platelet Collagen Receptor Glycoprotein VI* , 2003, The Journal of Biological Chemistry.

[24]  U. Heinzmann,et al.  A Crucial Role of Glycoprotein VI for Platelet Recruitment to the Injured Arterial Wall In Vivo , 2003, The Journal of experimental medicine.

[25]  S. Watson,et al.  Interaction of calmodulin with the cytoplasmic domain of platelet glycoprotein VI. , 2002, Blood.

[26]  Li-chao Zhao,et al.  Regulation of Membrane Metalloproteolytic Cleavage of L-selectin (CD62L) by the Epidermal Growth Factor Domain* , 2001, The Journal of Biological Chemistry.

[27]  C. Mitchell,et al.  Interaction of calmodulin with the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex. , 2001, Blood.

[28]  B. Nieswandt,et al.  Long-Term Antithrombotic Protection by in Vivo Depletion of Platelet Glycoprotein VI in Mice , 2001, The Journal of experimental medicine.

[29]  S. W. Hall,et al.  A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Bodnar,et al.  The Cytoplasmic Domain of the Platelet Glycoprotein Ibα Is Phosphorylated at Serine 609* , 1999, The Journal of Biological Chemistry.

[31]  T. Wells,et al.  The Platelet Collagen Receptor Glycoprotein VI Is a Member of the Immunoglobulin Superfamily Closely Related to FcαR and the Natural Killer Receptors* , 1999, The Journal of Biological Chemistry.

[32]  M. Jutila,et al.  Calmodulin Regulates L-Selectin Adhesion Molecule Expression and Function through a Protease-Dependent Mechanism , 1998, Cell.

[33]  M. Berndt,et al.  Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex. , 1988, Biochemistry.

[34]  H. Zola,et al.  Purification and preliminary characterization of the glycoprotein Ib complex in the human platelet membrane. , 1985, European journal of biochemistry.

[35]  B. Coller,et al.  Evidence that glycocalicin circulates in normal plasma. , 1984, The Journal of clinical investigation.

[36]  I. Peake International Society on Thrombosis and Haemostasis , 1974, Thrombosis and Haemostasis.